
AI-assisted international press reviewPress review

Gas Discovery at Gullfaks Field in the North Sea
Equinor and its partners have announced the discovery of gas at the Gullfaks South field, located 190 kilometers northwest of Bergen. This discovery could have implications for the energy market, but it does not fall within the scope of plant technologies or agritech, which focus on agricultural innovations and biotechnology.
Source: Equinor, published under the title "Gas discovery at the Gullfaks field in the North Sea" - 8 October 2026
Read more
Novartis Achieves Tier 1 Status in CCLA Corporate Mental Health Benchmark 2026
Novartis has been recognized for its commitment to workplace mental health, achieving the highest level in the CCLA Corporate Mental Health Benchmark 2026. This ranking highlights the importance of corporate culture, access to care, and awareness initiatives implemented to support employee well-being. With the launch of CareConnect, a global mental health assistance program, Novartis demonstrates its commitment to creating a work environment where mental health is a priority. Over 2,000 managers have been trained to promote awareness and reduce stigma around mental health, thereby strengthening the supportive culture within the company.
Source: Novartis, published under the title "Novartis achieves Tier 1 in the 2026 CCLA Corporate Mental H..." - 8 October 2026
Read more
Two Researchers Awarded the 2026 Nobel Prize in Chemistry
Professors Kenso Soai and Henri B. Kagan are honored with the 2026 Nobel Prize in Chemistry for their significant contributions to organic chemistry, particularly in the field of asymmetric synthesis. This award highlights the importance of their discoveries related to autocatalysis and nonlinear effects, showcasing the impact of their work on the scientific community and beyond.
Source: Takasago, published under the title "Professor Emeritus Kenso Soai and Professor Emeritus Henri B..." - 8 October 2026
Read more
FDA Approves Bayer's Application for Finerenone in Non-Diabetic CKD
Bayer has announced that the FDA has accepted its drug application for finerenone, aimed at treating chronic kidney disease (CKD) without diabetes. Results from the FIND-CKD study indicate that this treatment could slow disease progression and reduce cardiovascular events, providing a new option for the millions of patients affected by this often-overlooked condition.
Source: Bayer, published under the title "U.S. FDA accepts Bayer’s supplemental New Drug Application f..." - 8 October 2026
Read more
Novartis Receives FDA Approval for Rhapsido® to Treat Symptomatic Dermographism
Novartis' Rhapsido® (remibrutinib) is now the first approved treatment for symptomatic dermographism, providing a new option for patients whose symptoms are not controlled by antihistamines. This approval is based on promising clinical trial results, demonstrating superior efficacy compared to placebo and expanding the use of Rhapsido beyond chronic spontaneous urticaria. The implications of this advancement are significant for patients suffering from this debilitating condition.
Source: Novartis, published under the title "Novartis Rhapsido® (remibrutinib) receives FDA approval as f..." - 8 October 2026
Read more
Western Sydney Airport: A Model of Sustainability in Infrastructure
The Western Sydney International Airport project has achieved an exceptional sustainability score of 92.71, setting a new standard for infrastructure. Developed by CPB Contractors and ACCIONA, it incorporates innovations such as slipform paving while adhering to strict quality standards. This project demonstrates that it is possible to reconcile sustainability with technical excellence, while preparing infrastructure for future environmental challenges.
Source: Cimic, published under the title "Western Sydney Airport sets a new benchmark for sustainable ..." - 8 October 2026
Read more
Givaudan Supports Nepalese Communities Affected by Floods
Givaudan has donated 50,000 CHF to Action Against Hunger to assist communities in Nepal impacted by devastating floods caused by a glacier collapse. This support aims to address urgent needs for food, water, sanitation services, and mental health, as the humanitarian situation continues to deteriorate with thousands missing and infrastructure destroyed.
Source: Givaudan, published under the title "Givaudan donates CHF 50,000 to support flood-hit communities..." - 8 October 2026
Read more
Quarterly Update Ahead of Equinor's Financial Results
Equinor invites specialized analysts to submit their forecasts regarding the adjusted results for the third quarter. This initiative reflects a commitment to transparency and engagement with stakeholders, while also facilitating better anticipation of the company's financial performance in a constantly evolving market context.
Source: Equinor, published under the title "Quarterly update prior to financial reporting" - 7 October 2026
Read more
The Patient Who Transformed My Career: A Defining Turning Point
This article explores how a significant experience with a patient influenced a doctor's professional trajectory, highlighting the importance of human interactions in the healthcare field. While this narrative is poignant, it does not fall within the realm of plant technologies or agritech, focusing instead on the personal and emotional aspects of medical practice.
Source: Novartis, published under the title "The patient who changed the course of my career" - 7 October 2026
Read more
Abbott Launches Ensure Max Protein 3-in-1 for Muscle Support
Abbott introduces Ensure Max Protein 3-in-1, an innovative nutritional supplement that combines protein, creatine, and HMB to meet the growing demands for muscle health. This powder product aims to simplify the supplementation routine for consumers focused on strength and well-being, aligning with a trend in nutrition centered on longevity and physical performance.
Source: Abbott, published under the title "Abbott Introduces Ensure® Max Protein 3-In-1 Muscle Support,..." - 7 October 2026
Read more
Equinor Increases Snøhvit Future Project Cost to 26.5 Billion NOK
Equinor has revised the cost of the Snøhvit Future project upward to 26.5 billion NOK in 2026 value. The project timeline remains unchanged, with onshore compression expected to begin in 2029 and electrification in 2030, highlighting the significance of this project in the energy sector.
Source: Equinor, published under the title "Updated cost estimate for the Snøhvit Future project" - 7 October 2026
Read more
Novartis Unveils Advances in Multiple Sclerosis at MSToronto2026
At the 10th joint ACTRIMS-ECTRIMS meeting, Novartis will highlight key data on remibrutinib and Kesimpta, underscoring its commitment to innovation in multiple sclerosis treatment. Phase III clinical trial results and studies on pediatric treatments will be at the forefront of discussions, with a call to investors planned to delve deeper into these advancements.
Source: Novartis, published under the title "Novartis advances multiple sclerosis innovation with late-br..." - 7 October 2026
Read more
Takasago Shines at the 2026 International Symposium on Essential Oils
At the 56th International Symposium on Essential Oils (ISEO 2026) in Grasse, Takasago showcased significant advancements in the analysis of natural aromas, including an innovative method for determining the structure of volatile compounds and the reconstruction of a historical fragrance. The presentation was awarded for best poster, highlighting the importance of research in the field of essential oils and natural products.
Source: Takasago, published under the title "Oral and poster presentation at ISEO 2026" - 7 October 2026
Read more
Enel Becomes Official Energy Partner of Venezia FC for 2026/2027 Season
Venezia FC has announced a partnership with Enel, a leader in the energy sector, for the 2026/2027 season. As the Official Energy Partner and Premium Sponsor, Enel will showcase its brand at the training center and stadium, reinforcing its commitment to sports and local communities. This partnership illustrates Enel's desire to support teams deeply rooted in their cities while solidifying its position in Italian football.
Source: Enel, published under the title "Enel is the Official Energy Partner of Venezia FC for the 20..." - 7 October 2026
Read more
Iberdrola Strengthens Its Presence in Finland with Caruna Acquisition
Ignacio Galán's participation in a gala dinner with the Spanish royals highlights Iberdrola's growing importance in Finland, where the acquisition of Caruna, the leading electricity distributor, positions the company as the top Spanish investor in the country. This move is essential for the electrification of the Finnish economy and the rise of advanced technologies.
Source: Iberdrola, published under the title "Iberdrola’s Executive Chairman Ignacio Galán attends gala di..." - 7 October 2026
Read more
Bechtel and the University of South Carolina: A Partnership for Nuclear Future
Bechtel and the University of South Carolina announce a strategic partnership to develop the state's nuclear workforce, establishing a dedicated fund for education and training in the sector. This partnership aims to enhance the skills necessary to meet the growing demands of the nuclear industry, leveraging Bechtel's expertise and fostering collaborations between educational institutions and industry stakeholders.
Molly Edwards, Source: Bechtel, published under the title "Bechtel and USC Partner to Build South Carolina’s Nuclear Wo..." - 7 October 2026
Read more
Chloe Casserly: An Engineer Valuing Field Experience in Agritech
Chloe Casserly, a graduate engineer, shares her field experience as part of the Humelink West project, emphasizing the importance of problem-solving and teamwork. She encourages young professionals to embrace on-site work opportunities while highlighting the need for communication and planning skills in the engineering field.
Source: Cimic - 7 October 2026
Read more
Cabenuva: Promising Long-Acting HIV Treatment Shows Superior Results
The CROWN study reveals that the long-acting treatment Cabenuva outperforms daily oral therapy in achieving viral suppression among patients living with HIV-1. This advancement could transform treatment options for those with a history of non-adherence to antiretroviral therapies. The results, building on previous studies, will be submitted to health authorities for approval.
Source: Gsk, published under the title "ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabote..." - 7 October 2026
Read more
Mars Unveils the Future of Shopping: Towards Automated Grocery Experiences
Mars, the global leader in snacks, reveals insights into the evolution of retail, predicting an automation of grocery shopping and a transformation of physical stores into discovery spaces. Three key consumer demands emerge: effortless shopping, personalized experiences, and immersive destinations. The study, based on a thorough analysis of global data, calls for collaboration between brands and retailers to meet these new expectations and shape the future of the industry.
Source: Mars Incorporated, published under the title "Mars unveils the future of shopping and retail: New research..." - 6 October 2026
Read more
Sanofi Releases Memo for Q3 2026 Results Ahead of Publication
Sanofi has announced the availability of its memo for the third quarter 2026 results, which will be published on October 30, 2026. This document, prepared quarterly, aims to support the financial modeling of results by addressing non-comparable items and the impact of currencies. Sanofi, an innovative biopharmaceutical company, continues to focus on improving patients' lives through medications and vaccines based on a deep understanding of the immune system.
Source: Sanofi, published under the title "Press Release : Availability of the aide-mémoire for Q3 2026..." - 6 October 2026
Read more